Breast Cancer Clinical Trial
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study
Summary
This clinical trial studies the effect of a culturally based brief expressive writing intervention in improving the health of Chinese immigrant stage 0-III breast cancer survivors. Culturally based brief expressive writing interventions may help researchers learn more about the experiences of Chinese immigrant breast cancer survivors and how writing about their experiences may affect their health.
Full Description
PRIMARY OBJECTIVES:
I. To determine the health benefits of expressive writing compared with the control condition.
II. To characterize how acculturation moderates the effects of expressive writing interventions.
III. To identify mechanisms explaining the benefits of the interventions using mixed methods.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I (CONTROL): Patients write about facts regarding their cancer diagnosis and treatment for 3 weekly 30-minute sessions.
ARM II (SELF-REGULATION): Patients write about stress and coping, emotional disclosure, and benefit finding for 3 weekly 30-minute sessions.
ARM III (SELF-CULTIVATION): Patients write about positive thoughts and feelings regarding their breast cancer experience for 3 weekly 30-minute sessions.
After completion of study, patients are followed up at 6 weeks and at 6 and 12 months.
Eligibility Criteria
Inclusion Criteria:
Being diagnosed with stage 0-III breast cancer.
Completed primary treatment, including surgery, chemotherapy, radiation therapy, immune therapy, and/or targeted therapy within the preceding 5 years.
Comfortable reading Chinese.
Foreign-born Chinese women (aged 18 and older) who lived in the U.S. for at least six months in the past.
Exclusion Criteria:
1. Exclusion criteria include inability to provide informed consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Houston Texas, 77030, United States More Info
Principal Investigator
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.